Cochrane · systematic review · CD005004

Green tea (Camellia sinensis) for the prevention of cancer

Filippini, T, Malavolti, M, Borrelli, F, et al. · Cochrane Database of Systematic Reviews · 2020 · Cochrane Library

SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
22
current version
GRADE rated
21
No studies
1
Included studies
NR
No studies 1 · 4.5%Ungraded 0 · 0%Very low 6 · 27.3%Low 15 · 68.2%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Green tea extract supplementation compared with placebo for preventing cancer: experimental studies

Population: adults (aged at least 18 years)
4 questions
OutcomeEffectEvidenceStatus / GRADE
Prostate cancer incidence
Green tea extract supplementation vs placebo
RR 0.5 [0.18, 1.36]3 studies · 201 participantsLow
Gynaecological cancer incidence
Green tea extract supplementation vs placebo
RR 1.5 [0.41, 5.48]2 studies · 1157 participantsLow
Non‐melanoma skin cancer incidence
Green tea extract supplementation vs placebo
RR 1 [0.06, 15.92]1 study · 1075 participantsLow
Quality of life
Green tea extract supplementation vs placebo
no estimate extractedNRNo studies

Highest compared with lowest green tea exposure for preventing cancer: primary outcomes in nonexperimental studies

Population: adults (aged at least 18 years)
2 questions
OutcomeEffectEvidenceStatus / GRADE
Any cancer incidence (3 studies)
Highest vs lowest green tea exposure
RR 0.83 [0.65, 1.07]52479 participantsLow
Any cancer mortality (8 studies)
Highest vs lowest green tea exposure
RR 0.99 [0.91, 1.07]504366 participantsLow

Highest compared with lowest green tea exposure for preventing cancer: individual cancer types in nonexperimental studies

Population: adults (aged at least 18 years)
16 questions
OutcomeEffectEvidenceStatus / GRADE
Oral cancer risk (5 studies)
Highest vs lowest green tea exposure
RR 0.7155977 participantsLow
Any gut cancer risk (7 studies)
Highest vs lowest green tea exposure
RR 0.78 [0.59, 1.02]70299 participantsLow
Oesophageal cancer risk (13 studies)
Highest vs lowest green tea exposure
RR 0.81 [0.64, 1.04]74895 participantsVery low
Stomach cancer risk (18 studies)
Highest vs lowest green tea exposure
RR 0.86 [0.74, 1.01]438595 participantsVery low
Liver cancer risk (6 studies)
Highest vs lowest green tea exposure
RR 0.88 [0.68, 1.14]198885 participantsLow
Pancreatic cancer risk (9 studies)
Highest vs lowest green tea exposure
RR 0.88 [0.7, 1.1]326564 participantsLow
Colorectal cancer risk (16 studies)
Highest vs lowest green tea exposure
RR 0.84 [0.74, 0.96]610295 participantsLow
Colon cancer risk (10 studies)
Highest vs lowest green tea exposure
RR 0.89 [0.8, 0.98]389974 participantsLow
Rectal cancer risk (9 studies)
Highest vs lowest green tea exposure
RR 0.89 [0.75, 1.05]356851 participantsLow
Lung cancer risk (17 studies)
Highest vs lowest green tea exposure
RR 0.88 [0.76, 1.02]269565 participantsVery low
Breast cancer risk (14 studies)
Highest vs lowest green tea exposure
RR 0.88 [0.75, 1.02]250822 participantsVery low
Gynaecological cancer risk (10 studies)
Highest vs lowest green tea exposure
RR 0.69 [0.57, 0.83]66738 participantsLow
Endometrial cancer risk (5 studies)
Highest vs lowest green tea exposure
RR 0.77 [0.65, 0.91]60416 participantsLow
Ovarian cancer risk (5 studies)
Highest vs lowest green tea exposure
RR 0.64 [0.45, 0.9]6322 participantsLow
Prostate cancer risk (13 studies)
Highest vs lowest green tea exposure
RR 0.73 [0.56, 0.94]127239 participantsVery low
Urinary tract cancer risk (7 studies)
Highest vs lowest green tea exposure
RR 1.04 [0.79, 1.37]156039 participantsVery low